Connect with us

Hi, what are you looking for?

Thursday, Aug 28, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "CyPath Lung"

bioAffinity Technologies obtains Canadian patent for lung cancer spit test

bioAffinity Technologies obtains Canadian patent for lung cancer spit test

Medical and Pharmaceutical

bioAffinity Technologies obtains Canadian patent for lung cancer spit test

The CyPath Lung screening tool is also patented in China, Australia and Japan

Rowan DunneJuly 22, 2025

bioAffinity Technologies secures Australian patent for 'CyPath Lung' cancer spit test

bioAffinity Technologies secures Australian patent for 'CyPath Lung' cancer spit test

Medical and Pharmaceutical

bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test

It will be issued within 3 months provided that there are no opposition filings made by third parties

Rowan DunneJanuary 22, 2025

More Posts